Catalyst Wire Dossier Catalyst Wire Dossier

SpyGlass Bimatoprost Implant System

bimatoprost · SpyGlass Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SpyGlass Bimatoprost Implant System, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

See pricing